Recurrent Rhabdomyolysis: Evaluation and Management
For patients with recurrent rhabdomyolysis, you must systematically investigate for underlying metabolic myopathies, mitochondrial disorders, and glycogen storage diseases through genetic testing, muscle biopsy, and specialized exercise testing, while aggressively managing acute episodes with fluid resuscitation and monitoring for acute kidney injury.
Acute Episode Management
When a patient presents with recurrent rhabdomyolysis, the immediate priority is maintaining cardiac output while lowering potassium levels 1. This distinguishes management from malignant hyperthermia, where dantrolene is the priority. Key acute interventions include:
- Aggressive fluid therapy to prevent acute tubular necrosis from myoglobin 2, 3
- Correction of metabolic derangements, particularly hyperkalemia
- Monitor for acute kidney injury, especially when CK >16,000 IU/L (can reach >100,000 IU/L) 2
- Renal replacement therapy when warranted 3
The classic triad of myalgia, weakness, and pigmenturia occurs in <10% of patients 2, so maintain high clinical suspicion even without these findings.
Diagnostic Workup for Recurrent Episodes
Recurrent rhabdomyolysis (occurring in only 10% of cases) demands comprehensive investigation for underlying genetic disorders 2, 4. The evaluation should proceed algorithmically:
First-Line Investigations
Detailed history focusing on:
Genetic testing - Most valuable diagnostic tool:
Second-Line Investigations
Maximal cycle exercise testing (CPX):
Muscle biopsy:
EMG testing:
- Low yield: Only 20% show myopathic changes, and only half of those associate with underlying myopathy 6
- Consider if clinical examination suggests myopathy
Specific Metabolic Myopathies to Consider
Glycogen Storage Diseases
McArdle disease (glycogen storage disease type V) and aldolase A deficiency are associated with recurrent rhabdomyolysis triggered by intense physical activity, shivering, hypothermia, or decreased oxygen supply 1. These patients:
- Cannot convert glycogen to glucose in skeletal muscle 5
- Have low threshold for triggering rhabdomyolysis (e.g., 1 hour aerobic exercise on consecutive days) 5
- May have CK levels >320,000 U/L 5
- Often report decades of delay in diagnosis due to vague symptoms 5
CPT2 Deficiency
Carnitine palmitoyltransferase II deficiency is the most common long-chain fatty-acid oxidation disorder 1:
- Presents with exercise-induced muscle pain, weakness, or myoglobinuria
- Diagnosis: Reduced CPT enzyme activity in muscle or CPT2 gene variants 1
- Management: Low-fat (<20%) and high-carbohydrate diet; carnitine supplements 1
Mitochondrial Myopathies
Consider when CPX shows elevated cardiac output/VO2 max ratio 6:
- Fasting can trigger rhabdomyolysis 1
- Surgical stress, hypovolaemia, pain, and temperature fluctuations trigger acute lactic acidosis 1
- Coenzyme Q10 and carnitine supplementation may be beneficial 1
Prevention Strategies
For patients with identified metabolic myopathies:
- Avoid prolonged fasting or hypoglycemia - provide glucose-containing IV fluids 1
- Active prevention of hypothermia is mandatory 1
- Avoid triggers: intense physical activity, tourniquets, ischemia 1
- Educate on gradual return to activity - premature return is a major cause of recurrence 7
Perioperative Considerations
If surgery is required in patients with recurrent rhabdomyolysis from metabolic myopathy:
- Avoid propofol infusions for maintenance of anesthesia 1
- Avoid suxamethonium and acetylcholinesterase blockers 1
- Halogenated agents only at minimal dose and duration (<15 minutes) in CPT2 deficiency and McArdle disease 1
- Provide glucose-containing IV fluids perioperatively unless on ketogenic diet 1
- Monitor potassium frequently 1
Critical Pitfalls
- Do not dismiss recurrent episodes as coincidence - this represents a distinct syndrome requiring investigation 7
- Do not allow premature return to physical activity after an episode - this is a major cause of recurrence 7
- Do not rely solely on EMG or muscle biopsy - genetic testing and CPX have higher diagnostic yield 6
- Do not assume absence of acute kidney injury means mild disease - CK can be extraordinarily elevated without renal complications if managed early 4
When Investigation is Negative
When extensive workup reveals no definitive cause (common scenario):